Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

210,868 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improving the efficacy of conventional therapy by adding andrographolide sulfonate in the treatment of severe hand, foot, and mouth disease: a randomized controlled trial.
Li X, Zhang C, Shi Q, Yang T, Zhu Q, Tian Y, Lu C, Zhang Z, Jiang Z, Zhou H, Wen X, Yang H, Ding X, Liang L, Liu Y, Wang Y, Lu A. Li X, et al. Among authors: liu y. Evid Based Complement Alternat Med. 2013;2013:316250. doi: 10.1155/2013/316250. Epub 2013 Jan 15. Evid Based Complement Alternat Med. 2013. PMID: 23401711 Free PMC article.
[A multicenter prospective cohort study of Xuebijing injection in the treatment of severe coronavirus disease 2019].
Liu X, Song Y, Guan W, Qiu H, Du B, Li Y, Liu Y, Shang H, Zhong N, Coronavirus Disease Emergency Project Research Collaboration G. Liu X, et al. Among authors: liu y. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Jul;33(7):774-778. doi: 10.3760/cma.j.cn121430-20210514-00714. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34412743 Chinese.
A Case-Control Study of Continuous Veno-Venous Hemofiltration Combined with Xuebijing Injection in the Treatment of Severe Sepsis.
Liu Y, Wang B, Zhang Q, Zhao Y, Wang X. Liu Y, et al. Contrast Media Mol Imaging. 2022 May 28;2022:7884508. doi: 10.1155/2022/7884508. eCollection 2022. Contrast Media Mol Imaging. 2022. Retraction in: Contrast Media Mol Imaging. 2023 Sep 27;2023:9832798. doi: 10.1155/2023/9832798 PMID: 35685671 Free PMC article. Retracted. Clinical Trial.
210,868 results
You have reached the last available page of results. Please see the User Guide for more information.